Immunodeficiency Genetics Testing
Identifying the source to improve treatment outcomes and quality of life...
Our team at Brookside Clinical Laboratory provides accurate genetic testing information that can guide healthcare teams to create the most effective treatment plans. Immunodeficiency Genetics Testing can empower you to make informed decisions that enhance quality of life for your patients and raise awareness among their family members.
Along with our Genetic Immunodeficiency Testing services, we offer comprehensive support through trained geneticists. They can help you determine which patients should get tested and what you and your patients can expect throughout the process and take you through the result after the test is run so you can get any questions answered.
Who Should Get Immunodeficiency Genetic Testing?
Immunodeficiency Genetic Testing is ideal for patients with a personal or family history of ongoing or chronic issues, such as infections, fevers, and rashes that persist or keep coming back; as well as those with infections caused by an uncommon organism or those who require frequent hospitalizations or IV antibiotics.
An Immunodeficiency Genetic Panel can confirm a patient’s specific diagnosis and help physicians choose the best possible treatment method, including a personalized medical management plan and preventative steps. Experts recommend that children, siblings, and parents of patients who test positive for immunodeficiency variants also get tested.
Benefits of Genetic Testing for Primary Immunodeficiency Disorders
- Can quickly and accurately establish or confirm a diagnosis
- Can effectively identify patient risks for other associated symptoms
- Can use the information to advise patients to make lifestyle changes that help manage symptoms
- Can help providers create better, more personalized treatment and symptom management plans
- Can inform family members about their potential risk factors, so they can get tested and access medical care
Immunodeficiency Disorders We Test for:
- Hereditary angioedema (HAE)
- Autosomal dominant Hyper-IgE syndrome (AD-HIES)
- Autoimmune lymphoproliferative syndrome
- Crohn’s disease
- Autoimmune disorders
- Severe combined immunodeficiency
- Combined immunodeficiency
- Combined immunodeficiency with syndromic features
- Major histocompatibility complex class I and II deficiencies
- Dyskeratosis congenita
- Agammaglobulinemia and hypogammaglobulinemia
- Hyper-IgM syndrome
- Hyper-IgE syndrome, including Netherton’s syndrome
- Monogenic common variable immunodeficiency
- Chronic mucocutaneous candidiasis
- Herpes simplex encephalitis
- Epidermodysplasia verruciformis
- WHIM syndrome
- Mendelian susceptibility to mycobacterial infections
- Autoimmune lymphoproliferative syndrome
- Familial hemophagocytic lymphohistiocytosis and related disorders
- Hermansky-Pudlak syndrome
- Congenital neutropenia
- Chronic granulomatous disease
- Leukocyte adhesion deficiency
- Pulmonary alveolar proteinosis
Resources
Having a solid understanding of the most recent update in genomics testing can help you provide your patients with the best care possible. We offer resources so that you can stay up to date on any current news. Contact Brookside Clinical Laboratory with any additional questions.